Kilroy Realty Corporation

KRC
$39.32 (+ $0.16 + 0.41%)
Last updated: 2026-07-04 02:06 UTC
KRC Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorReal Estate
IndustryREIT - Office
ISINUS49427F1084
CUSIP49427F108
Market Price39.32
Dividend Yield 6.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 2.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyQuarterly
P/E Ratio14.02
EPS2.71
Market Cap$4.5B
Book Value46.2
Price to Book0.823
Beta1.08
52w High45.03
52w Low27.07
Next Earnings DateN/A

Kilroy Realty Corporation trades under ticker KRC on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Real Estate exposure. Identifiers: ISIN US49427F1084, CUSIP 49427F108. Also searched as Kilroy Realty.

Related researchKRC stock priceKRC share priceKRC dividend historyKRC dividend yieldKilroy Realty dividend historyKilroy Realty dividend yield49427F108Kilroy Realty stockKilroy Realty share price
About the Company
Kilroy is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust (“REIT”) and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of June 30, 2025, Kilroy's stabilized portfolio totaled approximately 16.4 million square feet of primarily office and life science space that was 80.8% occupied and 83.5% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 93.8%. In addition, the Company had one development project in the tenant improvement phase totaling approximately 875,000 square feet with a total estimated investment of $1.0 billion and two life science redevelopment projects in the tenant improvement phase totaling approximately 100,000 square feet with total estimated redevelopment costs of $85.0 million.
Price History